|Systematic (IUPAC) name|
|Mol. mass||167.21 g/mol|
p-Hydroxynorephedrine, or 4-hydroxynorephedrine, is the para-hydroxy analog of norephedrine and an active sympathomimetic metabolite of amphetamine in humans. When it occurs as a metabolite of amphetamine, it is produced from both p-hydroxyamphetamine and norephedrine.
Metabolic pathways of amphetamine
- "p-Hydroxynorephedrine". NCBI. PubChem Compound. Retrieved 25 October 2013.
- "Adderall XR Prescribing Information". Medication Guide. United States Food and Drug Administration. Retrieved 7 October 2013.
- "Amphetamine: Biomedical Effects and Toxicity". NCBI. Pubchem Compound. Retrieved 12 October 2013.
- Santagati NA, Ferrara G, Marrazzo A, Ronsisvalle G (September 2002). "Simultaneous determination of amphetamine and one of its metabolites by HPLC with electrochemical detection". J. Pharm. Biomed. Anal. 30 (2): 247–55. doi:10.1016/S0731-7085(02)00330-8. PMID 12191709.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|
|This article about an organic compound is a stub. You can help Wikipedia by expanding it.|